Concepedia

Philippe Rousselot

PR

Statistics

Publications

34

Citations

3.2K

H-Index

25

Active since

1995

Affiliations

Hôpital Saint-Louis(Current)

Assistance Publique – Hôpitaux de Paris

Inserm

Centre Hospitalier de Versailles

Hôpital Avicenne

Philippe Rousselot is an author at Hôpital Saint-Louis specializing in medicine, oncology, and hematologic malignancy therapy.

Publications per year

1995–2024

34

Publications

34

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Sylvie Castaigné, Cécile Pautas, Christine Terré et al. · The Lancet · 2012 · 995 citations

, , +10

Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.

Philippe Rousselot, S Labaume, Jean‐Pierre Marolleau et al. · PubMed · 1999 · 227 citations

, , +15

Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study

Cécile Pautas, Fatiha Merabet, Xavier Thomas et al. · Journal of Clinical Oncology · 2010 · 217 citations · Full text

, , +16

<i>In vivo</i> mechanisms of resistance to cytarabine in acute myeloid leukaemia

Carlos M. Galmarini, Xavier Thomas, Fabien Calvo et al. · British Journal of Haematology · 2002 · 161 citations · Full text

, , +17

Expression and prognostic significance of survivin in<i>de novo</i>acute myeloid leukaemia

Colette Adida, Christian Récher, Emmanuel Raffoux et al. · British Journal of Haematology · 2000 · 161 citations

, , +11

1–5 of 34